Primaquine is the only available antimalarial drug that kills dormant liver stages of
Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse …

Malaria is one of the major global health concerns that affect millions of people worldwide
annually, especially people residing in the developing countries. The previously …

Background Artemisinin-based combination therapy (ACT) was deployed in 2005 as an
alternative to chloroquine and is considered the most efficacious treatment currently …

Background Malaria is a major public health problem in endemic countries including Sudan,
where about 75% of populations are at risk. Due to widespread of chloroquine-resistant …

Lung cancer is one of the deadliest cancers worldwide due to chemoresistance in patients
with late-stage disease. Quinoline derivatives show biological activity against HIV, malaria …

Malaria disease is a public health problem especially in tropical countries, 445.000 of
malaria-related deaths have been reported in 2017. MicroRNAs (miRNAs) are small non …

Malaria is a leading public health problem in tropical and subtropical countries of the world.
In 2019, there were an estimated 229 million malaria cases and 409, 000 deaths due …

Background Regular monitoring of anti-malarial drug efficacy is vital for establishing rational
malaria treatment guidelines and ensuring adequate treatment outcomes. This study aimed …

Background Malaria remains a major global health problem although there was a
remarkable achievement between 2000 and 2015. Malaria drug resistance, along with …

Background Malaria and visceral leishmaniasis (VL) co-infection can occur due to the
overlapping geographical distributions of these diseases; however, only limited data of this …